0
Slide Presentations: Sunday, October 31, 2010 |

Metabolic Syndrome Is Associated With Increased Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Preliminary Study FREE TO VIEW

Elif Kupeli, MD; Gaye Ulubay, MD; Sevinc Sarinc Ulasli, MD; Tugce Sahin, MD; Zeynep Erayman, MD; Alptekin Gürsoy, MD
Author and Funding Information

Baskent University School of Medicine Pulmonary Department, Ankara, Turkey



Chest. 2010;138(4_MeetingAbstracts):711A. doi:10.1378/chest.9878
Text Size: A A A
Published online

Abstract

PURPOSE: Studies have confirmed correlation between Metabolic Syndrome (MetS) and Chronic Obstructive Pulmonary Disease (COPD). However, to date, no studies have analyzed correlation between exacerbations of COPD (ECOPD) and MetS. Aim of this preliminary study was to examine if presence of MetS increases the frequency and duration of ECOPD.

METHODS: Patients with COPD were prospectively enrolled and followed between March 2008 and September 2009. Medical records, pulmonary function tests, chest X-rays; laboratory test results were gathered to establish the presence of COPD and MetS. Patients were divided in two groups; with and without MetS. The ECOPD was defined as worsening of symptoms requiring increased use of rescue medications and/or need for either systemic steroids or antibiotics or that led to emergency room visit or hospitalizations during 12 months follow-up.

RESULTS: A total of 106 patients were recruited, 29 with MetS and 77 without. The mean exacerbation of COPD frequency was 2.4 ± 0.8 in MetS group versus 0.68 ± 0.6 in the control group during the follow-up period (P < 0.001). Mean duration of each exacerbation was 7.5 ± 1.5 days in patients with MetS versus 5 ± 2.4 days in patients without. Serum C-reactive protein, fasting blood glucose, and triglycerides were positively and significantly correlated with exacerbation frequency.

CONCLUSION: Present preliminary study demonstrates an association between ECOPD and its duration with the MetS. The systemic inflammation induced by common cytokines may explain the linkage between the two conditions.

CLINICAL IMPLICATIONS: COPD and MetS share common pathophysiologic features; chronic systemic inflammation has been implicated as a major causative factor for both disorders. Recently, it has been shown that the presence of MetS is frequent in patients with COPD. MetS may be a risk factor for increased number of exacerbation and its duration in COPD patients due to the shared inflammatory cytokine burden.

DISCLOSURE: Elif Kupeli, No Financial Disclosure Information; No Product/Research Disclosure Information

09:45 AM - 11:00 AM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543